Macau, China vs Saudi Arabia: HIV-positive TB patients on ART (antiretroviral therapy)
Macau, China
100.0%
in 2024
Saudi Arabia
100.0%
in 2024
Macau, China rank
1st
Saudi Arabia rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Macau, China
- Saudi Arabia
How they compare
Macau, China currently reports 100.0% against 100.0% in Saudi Arabia, a difference of 0.0%.
Across all 10 years both countries report, Saudi Arabia has been ahead every year.
Macau, China ranks 1st and Saudi Arabia ranks 1st of 144 countries.
Saudi Arabia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Macau, China | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 62.5% | 100.0% | 37.5% | Saudi Arabia |
| 2010s | 72.3% | 98.7% | 26.3% | Saudi Arabia |
| 2020s | 78.4% | 100.0% | 21.6% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Macau, China or Saudi Arabia?
- Macau, China, at 100.0% against 100.0% in Saudi Arabia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Macau, China and Saudi Arabia?
- 0.0%, with Macau, China ahead.
- How many years of comparable data are there for Macau, China and Saudi Arabia?
- 10 years are reported by both, from 2007 to 2024.
- How do Macau, China and Saudi Arabia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Macau, China ranks 1st and Saudi Arabia ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.